Related Experiment Videos
Abetalipoproteinaemia. A case report with pathological studies.
Postgraduate Medical Journal
|November 1, 1976
Summary
Abetalipoproteinemia, a rare genetic disorder, can cause neurological issues like reduced eye movement speed. Vitamin E therapy, often used for this condition, proved ineffective in this specific case.
Area of Science:
- Neuro-ophthalmology
- Medical genetics
- Neuropathology
Background:
- Abetalipoproteinemia is a rare autosomal recessive disorder of lipid metabolism.
- It is characterized by the inability to synthesize or secrete apolipoprotein B-containing lipoproteins.
- Clinical manifestations include fat malabsorption, retinitis pigmentosa, and progressive neurological dysfunction.
Observation:
- A 38-year-old patient with abetalipoproteinemia presented with detailed clinical and pathological features.
- A novel observation was a marked reduction in the velocity of ocular horizontal saccadic movements.
- Pathological examination revealed an active chronic demyelinating process.
Findings:
- The patient exhibited neurological symptoms consistent with abetalipoproteinemia, including impaired saccadic eye movements.
- Histopathological analysis confirmed a demyelinating process in the nervous system.
- Despite high doses of vitamin E, the patient showed no clinical improvement.
Implications:
- This case highlights a previously unrecorded feature of abetalipoproteinemia, specifically reduced saccadic velocity.
- The findings suggest that the demyelinating process in this condition may not be solely attributable to vitamin E deficiency or oxidative stress.
- The lack of response to vitamin E warrants further investigation into alternative therapeutic strategies and the underlying pathophysiology of neurological decline in abetalipoproteinemia.